| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 9 Oct 2025 | 3 Oct 2025 |
| Astal Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/10/2025 inter alia to consider and approve 1) To increase authorised share capital of the Company in accordance with Companies Act 2013 and subject to any regulatory/ statutory approvals as may be required and the approval of the shareholders of the Company; 2) To consider and if thought fit approve the issuance of equity shares / convertible warrants of the Company on a preferential basis in accordance with the Companies Act 2013 read with the rules notified thereunder each as amended and the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations 2018 as amended and such other acts rules and regulations as may be applicable subject to any regulatory/ statutory approvals as may be required and the approval of the shareholders of the Company; and other items. Submission of outcome of Board meeting. (As Per BSE Announcement Dated on: 09/10/2025) Submission of intimation of preferential issue of equity shares. (As Per Bse Announcement dated on 10/10/2025) | ||
| Board Meeting | 12 Aug 2025 | 6 Aug 2025 |
| Astal Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2025 inter alia to consider and approve Submission of prior intimation of board meeting to be held on Tuesday 12th August 2025 to transact the business as mentioned herewith. Submission of Outcome of board meeting held on 12th August, 2025. (As per BSE Announcement Dated on 12/08/2025) | ||
| Board Meeting | 19 May 2025 | 13 May 2025 |
| Astal Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/05/2025 inter alia to consider and approve the audited standalone financial results for the quarter and year ended March 31 2025 along with limited review report of the auditors and other businesses. Submission of intimation of appointment of Secretarial Auditor. Submission of outcome of the meeting of the board of directors held on Monday 19th May, 2025. Submission of audited financial results for the quarter and year ended 31 March, 2025. (As Per BSE Announcement Dated on: 19/05/2025) | ||
| Board Meeting | 27 Jan 2025 | 21 Jan 2025 |
| Quarterly Results Astal Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/01/2025 ,inter alia, to consider and approve Submission of prior intimation of Board meeting to be held on 27th January 2025 to approve unaudited financial results for the quarter ended 31st December 2024. Submission of intimation of Board meeting outcome. Submission of unaudited financial results for the quarter ended 31st December 2024. (As per BSE Announcement Dated on 27/01/2025) | ||
| Board Meeting | 27 Nov 2024 | 22 Nov 2024 |
| Astal Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/11/2024 inter alia to consider and approve Allotment of 4079930 Convertible Warrants convertible into equity shares of face value of Rs. 10/- each at premium of Rs. 30/- each to Strategic Investors (Non-Promoters) on Preferential basis. To discuss any other matter with the permission of the chairperson. Intimation of the Outcome of the Meeting of the Board held on 27th November, 2024 pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) (LODR) Regulations, 2015. (As Per BSE Announcement dated on 27.11.2024) | ||
| Board Meeting | 12 Nov 2024 | 6 Nov 2024 |
| Quarterly Results Submission of unaudited financial results for the quarter ended 30th September 2024. Intimation of outcome of Board Meeting held on 12th November 2024. (As Per BSE Announcement Dated on: 12/11/2024) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.